About Bioventus
Bioventus is a company based in Durham (United States) founded in 2012. The company has 930 employees as of December 31, 2024. Bioventus has completed 4 acquisitions, including BioStructures, Bioness and CartiHeal. Bioventus offers products and services including StimRouter and EXOGEN.
- Headquarter Durham, United States
- Employees 930 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioventus Inc.
-
Annual Revenue
$573.28 M (USD)11.89as on Dec 31, 2024
-
Net Profit
-$33.54 M (USD)78.53as on Dec 31, 2024
-
EBITDA
$94.45 M (USD)28.72as on Dec 31, 2024
-
Latest Funding Round
$12 M (USD), Debt – Venture
Oct 27, 2014
-
Investors
Alcentra
& 1 more
-
Employee Count
930
as on Dec 31, 2024
-
Investments & Acquisitions
BioStructures
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bioventus
Bioventus is a publicly listed company on the NASDAQ with ticker symbol BVS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bioventus
Bioventus offers a comprehensive portfolio of products and services, including StimRouter and EXOGEN.
This device is utilized for providing relief from chronic peripheral nerve pain through the delivery of electrical pulses
This system is employed for aiding bone healing and is made available to support patient recovery in orthopedic care
People of Bioventus
Unlock access to complete
Software Development Team
64 people
Sales and Marketing
41 people
Finance and Accounting
18 people
Product Management Team
11 people
Leadership Team
9 people
Board Team
9 people
Senior Team
9 people
Legal and Compliance
6 people
Unlock access to complete
Funding Insights of Bioventus
Investors in Bioventus
Bioventus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Alcentra and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Locked | Locked | Locked | |
|
Alcentra is engaged in alternative credit investment management.
|
Locked | Locked | Locked |
Investor details for Bioventus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioventus
Bioventus has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include BioStructures, Bioness and CartiHeal.
Investment portfolio details for Bioventus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develop platforms in bioresorbable bone graft products
|
Locked | Locked | 2009 | Locked | |
|
Implants for bone and cartilage regeneration are developed and provided.
|
Locked | Locked | 2009 | Locked | |
|
Mobility aids for CNS disorders and orthopedic injuries are developed.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Bioventus
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bioventus
Detailed financials for Bioventus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioventus Comparisons
Peer comparison for Bioventus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioventus
Detailed competitors of Bioventus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioventus
Complete news archive for Bioventus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioventus
Bioventus was founded in 2012.
Bioventus is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
As of Dec 31, 2024, the latest employee count at Bioventus is 930.
Annual revenue of Bioventus is $573.28M as on Dec 31, 2024.
Bioventus was founded in 2012 and is headquartered in Durham, United States. Orthobiologic and regenerative medicine products are developed and manufactured by the company within the healthcare sector. Focus is placed on therapies for musculoskeletal conditions, including bone and cartilage repair. Operations involve research, production, and distribution primarily from U.S. facilities, serving clinicians and patients worldwide through established medical channels.
Bioventus offers StimRouter and EXOGEN.
Yes, Bioventus is publicly traded on NASDAQ under the ticker symbol BVS.
Bioventus has made 4 acquisitions, including BioStructures, Bioness, and CartiHeal.
Bioventus has 2 investors. Key investors include Alcentra, and EW Healthcare Partners.
The ticker symbol of Bioventus is BVS on NASDAQ.